Localized Bladder Cancer
Localized Bladder Cancer is a type of cancer that starts in the bladder and is confined to the bladder wall, often causing symptoms like blood in urine, frequent urination, and pelvic pain.
Bladder Cancer: Erdafitinib Delivery System Study
We are testing a new way to deliver Erdafitinib for people with non-muscle-invasive or muscle-invasive bladder cancer. The goal is to see how safe it is and how well it works compared to standard treatments.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Urologicum Duisburg
Urologicum Duisburg
Dinslaken, Germany
Universitaetsklinikum Carl Gustav Carus Dresden an der Technischen Universitaet Dresden AöR
Klinik und Poliklinik für Urologie
Dresden, Germany
Universitaetsklinikum Frankfurt AöR
Klinik fuer Urologie
Frankfurt am Main, Germany
Sponsor: Janssen - Cilag International
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.